| TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells S Mariathasan, SJ Turley, D Nickles, A Castiglioni, K Yuen, Y Wang, ... Nature 554 (7693), 544-548, 2018 | 3843 | 2018 |
| Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury WR Proctor, AJ Foster, J Vogt, C Summers, B Middleton, MA Pilling, ... Archives of toxicology 91, 2849-2863, 2017 | 276 | 2017 |
| Phase 2 randomized trial of the safety and efficacy of MHAA4549A, a broadly neutralizing monoclonal antibody, in a human influenza A virus challenge model JM McBride, JJ Lim, T Burgess, R Deng, MA Derby, M Maia, P Horn, ... Antimicrobial agents and chemotherapy 61 (11), 10.1128/aac. 01154-17, 2017 | 67 | 2017 |
| A cost-effectiveness framework for COVID-19 treatments for hospitalized patients in the United States D Sheinson, J Dang, A Shah, Y Meng, D Elsea, S Kowal Advances in Therapy 38, 1811-1831, 2021 | 53 | 2021 |
| Comparison of the performance of particle filter algorithms applied to tracking of a disease epidemic DM Sheinson, J Niemi, W Meiring Mathematical biosciences 255, 21-32, 2014 | 41 | 2014 |
| Correlation of cytomegalovirus (CMV) disease severity and mortality with CMV viral burden in CMV-seropositive donor and CMV-seronegative solid organ transplant recipients JM McBride, D Sheinson, J Jiang, N Lewin-Koh, BG Werner, JKL Chow, ... Open forum infectious diseases 6 (2), ofz003, 2019 | 39 | 2019 |
| Trends in use of next-generation sequencing in patients with solid tumors by race and ethnicity after implementation of the Medicare national coverage determination DM Sheinson, WB Wong, CS Meyer, S Stergiopoulos, KT Lofgren, ... JAMA Network Open 4 (12), e2138219-e2138219, 2021 | 23 | 2021 |
| Association between Medicare's national coverage determination and utilization of next-generation sequencing DM Sheinson, WB Wong, C Flores, S Ogale, CP Gross JCO Oncology Practice 17 (11), e1774-e1784, 2021 | 23 | 2021 |
| Five-year patterns of diabetic retinopathy progression in US clinical practice A Moshfeghi, V Garmo, D Sheinson, A Ghanekar, I Abbass Clinical Ophthalmology, 3651-3659, 2020 | 23 | 2020 |
| Persistence and adherence to ocrelizumab compared with other disease-modifying therapies for multiple sclerosis in US commercial claims data NJ Engmann, D Sheinson, K Bawa, CD Ng, G Pardo Journal of Managed Care & Specialty Pharmacy 27 (5), 639-649, 2021 | 19 | 2021 |
| In vitro assessment of chemotherapy-induced neuronal toxicity C Snyder, L Yu, T Ngo, D Sheinson, Y Zhu, M Tseng, D Misner, K Staflin Toxicology in vitro 50, 109-123, 2018 | 19 | 2018 |
| Impact of delaying initiation of anaplastic lymphoma kinase inhibitor treatment on survival in patients with advanced non-small-cell lung cancer D Sheinson, WB Wong, N Wu, AS Mansfield Lung Cancer 143, 86-92, 2020 | 18 | 2020 |
| Burden and cost of comorbidities in patients with neuromyelitis optica spectrum disorder A Exuzides, D Sheinson, P Sidiropoulos, F Magrini, S Gholizadeh, ... Journal of the Neurological Sciences 427, 117530, 2021 | 16 | 2021 |
| Variance component analysis of circulating miR-122 in serum from healthy human volunteers J Vogt, D Sheinson, P Katavolos, H Irimagawa, M Tseng, KR Alatsis, ... PLoS One 14 (7), e0220406, 2019 | 16 | 2019 |
| Impact of immune checkpoint inhibitors on COVID-19 severity in patients with cancer R Tan, C Yun, A Seetasith, D Sheinson, R Walls, I Ngwa, JC Reddy, ... The Oncologist 27 (3), 236-243, 2022 | 15 | 2022 |
| The association between persistence and adherence to disease-modifying therapies and healthcare resource utilization and costs in patients with multiple sclerosis G Pardo, ED Pineda, CD Ng, D Sheinson, NG Bonine Journal of Health Economics and Outcomes Research 9 (1), 111, 2022 | 13 | 2022 |
| Are National Comprehensive Cancer Network evidence block affordability ratings representative of real-world costs? An evaluation of advanced Non–small-cell lung cancer JT Cohen, PJ Lin, DM Sheinson, WB Wong, N Wu, YM Yim, SD Ramsey Journal of oncology practice 15 (11), e948-e956, 2019 | 13 | 2019 |
| The impact of funding inpatient treatments for COVID-19 on health equity in the United States: a distributional cost-effectiveness analysis S Kowal, CD Ng, R Schuldt, D Sheinson, R Cookson Value in Health 26 (2), 216-225, 2023 | 12 | 2023 |
| HER2-positive metastatic breast cancer: a retrospective cohort study of healthcare costs in the targeted-therapy age JA Sussell, D Sheinson, N Wu, B Shah-Manek, A Seetasith Advances in Therapy 37, 1632-1645, 2020 | 12 | 2020 |
| Rapid development of glaucoma via ITV nonselective ANGPT 1/2 antibody: a potential role for ANGPT/TIE2 signaling in primate aqueous humor outflow EA Thackaberry, Y Zhou, CLZ de Zafra, G Fuh, CV Lee, S Sanowar, ... Investigative Ophthalmology & Visual Science 60 (13), 4097-4108, 2019 | 11 | 2019 |
Jarad NiemiIowa State University在 iastate.edu 的电子邮件经过验证
